Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger R C New

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Molecules (Basel, Switzerland)|December 29, 2020
Binding Interactions of Peptide AptamersRoger R C New, Tam T T Bui, Michal Bogus
Diabetes, Obesity & Metabolism|November 15, 2022
Safety and efficacy of an oral insulin (Capsulin) in patients with early-stage type 2 diabetes: A dose-ranging phase 2b studyRoger R C New, Sukumar Ramanujam, Varsha Chaudhari, et al.
Clinical and Vaccine Immunology : CVI|September 24, 2010
Lipopolysaccharide as an antigen target for the formulation of a universal vaccine against Escherichia coli O111 strainsMaurílio F Santos, Roger R C New, Gabrielle R Andrade, et al.
Human Vaccines & Immunotherapeutics|December 9, 2014
A universal polysaccharide conjugated vaccine against O111 E. coliGabrielle R Andrade, Roger R C New, Osvaldo A Sant'Anna, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Molecules (Basel, Switzerland)|December 29, 2020
Binding Interactions of Peptide AptamersRoger R C New, Tam T T Bui, Michal Bogus
Diabetes, Obesity & Metabolism|November 15, 2022
Safety and efficacy of an oral insulin (Capsulin) in patients with early-stage type 2 diabetes: A dose-ranging phase 2b studyRoger R C New, Sukumar Ramanujam, Varsha Chaudhari, et al.
Clinical and Vaccine Immunology : CVI|September 24, 2010
Lipopolysaccharide as an antigen target for the formulation of a universal vaccine against Escherichia coli O111 strainsMaurílio F Santos, Roger R C New, Gabrielle R Andrade, et al.
Human Vaccines & Immunotherapeutics|December 9, 2014
A universal polysaccharide conjugated vaccine against O111 E. coliGabrielle R Andrade, Roger R C New, Osvaldo A Sant'Anna, et al.
Pageof 1